AstraZeneca refutes reports suggesting its COVID-19 vaccine efficacy could be as low as 8% in people aged over 65

AZ rebutting the earlier dissing – German press (Handelsblatt) had the ‘8%’ claim.

Demand for their vaccine is through the roof causing delays in deliveries.